- Home
- EWTX vs LXP Comparison
EWTX vs LXP Comparison
Compare EWTX & LXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- LXP
- Stock Information
- Founded
- EWTX 2017
- LXP 1993
- Country
- EWTX United States
- LXP United States
- Employees
- EWTX 117
- LXP N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- LXP Real Estate Investment Trusts
- Sector
- EWTX Health Care
- LXP Real Estate
- Exchange
- EWTX Nasdaq
- LXP Nasdaq
- Market Cap
- EWTX 1.5B
- LXP 2.6B
- IPO Year
- EWTX 2021
- LXP 1993
- Fundamental
- Price
- EWTX $13.01
- LXP $8.39
- Analyst Decision
- EWTX Buy
- LXP Hold
- Analyst Count
- EWTX 9
- LXP 3
- Target Price
- EWTX $39.89
- LXP $10.50
- AVG Volume (30 Days)
- EWTX 936.5K
- LXP 3.5M
- Earning Date
- EWTX 08-07-2025
- LXP 07-30-2025
- Dividend Yield
- EWTX N/A
- LXP 6.47%
- EPS Growth
- EWTX N/A
- LXP 402.06
- EPS
- EWTX N/A
- LXP 0.20
- Revenue
- EWTX N/A
- LXP $361,070,000.00
- Revenue This Year
- EWTX N/A
- LXP N/A
- Revenue Next Year
- EWTX N/A
- LXP $7.28
- P/E Ratio
- EWTX N/A
- LXP $42.56
- Revenue Growth
- EWTX N/A
- LXP 5.67
- 52 Week Low
- EWTX $10.60
- LXP $6.85
- 52 Week High
- EWTX $38.12
- LXP $10.57
- Technical
- Relative Strength Index (RSI)
- EWTX 35.24
- LXP 45.51
- Support Level
- EWTX $12.72
- LXP $8.13
- Resistance Level
- EWTX $13.84
- LXP $8.53
- Average True Range (ATR)
- EWTX 0.67
- LXP 0.19
- MACD
- EWTX -0.18
- LXP -0.05
- Stochastic Oscillator
- EWTX 24.36
- LXP 34.00
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About LXP LXP Industrial Trust (Maryland REIT)
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.